110 related articles for article (PubMed ID: 23081917)
1. Water-soluble cationic derivatives of indirubin, the active anticancer component from Indigo naturalis.
Ginzinger W; Egger A; Mühlgassner G; Arion VB; Jakupec MA; Galanski M; Berger W; Keppler BK
Chem Biodivers; 2012 Oct; 9(10):2175-85. PubMed ID: 23081917
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxicity of novel indirubin-5-carboxamides.
Cheng X; Rasqué P; Vatter S; Merz KH; Eisenbrand G
Bioorg Med Chem; 2010 Jun; 18(12):4509-15. PubMed ID: 20488718
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule.
Cheng X; Merz KH; Vatter S; Zeller J; Muehlbeyer S; Thommet A; Christ J; Wölfl S; Eisenbrand G
J Med Chem; 2017 Jun; 60(12):4949-4962. PubMed ID: 28557430
[TBL] [Abstract][Full Text] [Related]
4. Indirubin-3'-oxime impairs mitochondrial oxidative phosphorylation and prevents mitochondrial permeability transition induction.
Varela AT; Gomes AP; Simões AM; Teodoro JS; Duarte FV; Rolo AP; Palmeira CM
Toxicol Appl Pharmacol; 2008 Dec; 233(2):179-85. PubMed ID: 18786556
[TBL] [Abstract][Full Text] [Related]
5. 5-Bromoindirubin 3'-(O-oxiran-2-ylmethyl)oxime: A long-acting anticancer agent and a suicide inhibitor for epoxide hydrolase.
Ichimaru Y; Fujii T; Saito H; Sano M; Uchiyama T; Miyairi S
Bioorg Med Chem; 2017 Sep; 25(17):4665-4676. PubMed ID: 28743492
[TBL] [Abstract][Full Text] [Related]
6. Indirubin 3'-(O-oxiran-2-ylmethyl)oxime: a novel anticancer agent.
Ichimaru Y; Saito H; Uchiyama T; Metori K; Tabata K; Suzuki T; Miyairi S
Bioorg Med Chem Lett; 2015 Apr; 25(7):1403-6. PubMed ID: 25765906
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro.
Kim SH; Choi SJ; Kim YC; Kuh HJ
Arch Pharm Res; 2009 Jun; 32(6):915-22. PubMed ID: 19557370
[TBL] [Abstract][Full Text] [Related]
8. 5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity.
Choi SJ; Lee JE; Jeong SY; Im I; Lee SD; Lee EJ; Lee SK; Kwon SM; Ahn SG; Yoon JH; Han SY; Kim JI; Kim YC
J Med Chem; 2010 May; 53(9):3696-706. PubMed ID: 20361800
[TBL] [Abstract][Full Text] [Related]
9. Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component.
Lin YK; Leu YL; Yang SH; Chen HW; Wang CT; Pang JH
J Dermatol Sci; 2009 Jun; 54(3):168-74. PubMed ID: 19303259
[TBL] [Abstract][Full Text] [Related]
10. Asymmetrically substituted cationic indole- and fluorene porphyrins inhibit tumor proliferation in small intestinal neuroendocrine tumors and medullary thyroid carcinomas.
Haeubl M; Schuerz S; Svejda B; Reith LM; Gruber B; Pfragner R; Schoefberger W
Eur J Med Chem; 2010 Feb; 45(2):760-73. PubMed ID: 19939515
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer activity of Indolin-2-one derivatives bearing the 4-thiazolidinone moiety.
Wang S; Zhao Y; Zhu W; Liu Y; Guo K; Gong P
Arch Pharm (Weinheim); 2012 Jan; 345(1):73-80. PubMed ID: 21932254
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel indirubin-3'-monoxime derivatives as potent inhibitors against CDK2 and CDK9.
Yan L; Lai F; Chen X; Xiao Z
Bioorg Med Chem Lett; 2015 Jun; 25(11):2447-51. PubMed ID: 25908517
[TBL] [Abstract][Full Text] [Related]
13. Novel approach to bis(indolyl)methanes: de novo synthesis of 1-hydroxyiminomethyl derivatives with anti-cancer properties.
Grosso C; Cardoso AL; Lemos A; Varela J; Rodrigues MJ; Custódio L; Barreira L; Pinho e Melo TM
Eur J Med Chem; 2015 Mar; 93():9-15. PubMed ID: 25644672
[TBL] [Abstract][Full Text] [Related]
14. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
[TBL] [Abstract][Full Text] [Related]
15. Regioselective one pot synthesis of 3,3'-diindolylethylene derivatives and study of their cytotoxic activity.
Mandal M; Kumar D; Roy R; Sen R; Das P; Chatterjee M; Jaisankar P
Bioorg Med Chem Lett; 2011 May; 21(10):3084-7. PubMed ID: 21459575
[TBL] [Abstract][Full Text] [Related]
16. New water soluble pyrroloquinoline derivatives as new potential anticancer agents.
Ferlin MG; Marzano C; Dalla Via L; Chilin A; Zagotto G; Guiotto A; Moro S
Bioorg Med Chem; 2005 Aug; 13(15):4733-9. PubMed ID: 15936202
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity against KB and NCI-H187 cell lines of modified flavonoids from Kaempferia parviflora.
Yenjai C; Wanich S
Bioorg Med Chem Lett; 2010 May; 20(9):2821-3. PubMed ID: 20362442
[TBL] [Abstract][Full Text] [Related]
18. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells.
Kameswaran TR; Ramanibai R
Biomed Pharmacother; 2009 Feb; 63(2):146-54. PubMed ID: 18450412
[TBL] [Abstract][Full Text] [Related]
19. Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties.
Liu P; Lu Y; Gao X; Liu R; Zhang-Negrerie D; Shi Y; Wang Y; Wang S; Gao Q
Chem Commun (Camb); 2013 Mar; 49(24):2421-3. PubMed ID: 23420130
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 4-anilinofuro[2,3-b]quinoline derivatives as selective and orally active compounds against non-small-cell lung cancers.
Chen YW; Chen YL; Tseng CH; Liang CC; Yang CN; Yao YC; Lu PJ; Tzeng CC
J Med Chem; 2011 Jul; 54(13):4446-61. PubMed ID: 21599000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
